EIGER BIOPHARMACEUTICALS INC (EIGR) Stock Balance Sheet
USA - NASDAQ:EIGR - US28249U2042 - Common Stock
1.725 USD
-0.17 (-9.21%)
1.7 USD
-0.03 (-1.45%)
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 25.44M | 25.80M | 22.20M | 28.90M | 39.40M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 0 | 73.20M | 66.60M | 100.00M | 55.60M | |||
| Receivables | 1.68M | 1.70M | 2.60M | null | null | |||
| Inventories | 1.56M | 2.90M | 2.60M | null | null | |||
| Other Current Assets | 9.16M | 14.00M | 9.40M | 9.00M | 5.40M | |||
| Total Current Assets | 37.84M | 117.50M | 103.40M | 137.80M | 100.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 627.00K | 1.30M | 1.30M | 1.90M | 2.20M | |||
| Investments And Advances | null | 0 | 17.30M | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 360.00K | 1.30M | 4.50M | 3.90M | 2.50M | |||
| Total Non-Current Assets | 987.00K | 2.60M | 23.00M | 5.80M | 4.70M | |||
| TOTAL ASSETS | 38.83M | 120.10M | 126.40M | 143.60M | 105.10M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 41.12M | 0 | 7.80M | null | null | |||
| Accrued Expenses | 10.05M | 16.10M | 14.30M | 12.00M | 10.50M | |||
| Accounts Payable | 2.12M | 9.00M | 7.80M | 4.60M | 6.40M | |||
| Other Current Liabilities | null | 25.12M | null | null | null | |||
| Total Current Liabilities | 53.28M | 25.10M | 29.90M | 16.60M | 16.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 39.60M | 24.00M | 31.20M | 30.40M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 0 | 100.00K | 100.00K | 700.00K | 1.30M | |||
| Total Non-Current Liabilities | 0 | 39.70M | 24.10M | 32.00M | 31.80M | |||
| TOTAL LIABILITIES | 53.28M | 64.80M | 54.00M | 48.60M | 48.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -512.16M | -437.20M | -340.40M | -306.50M | -241.40M | |||
| Additional Paid In Capital | 497.87M | 492.80M | 412.90M | 401.50M | 297.90M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 1.00K | 0 | 0 | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -169.00K | -300.00K | -100.00K | 0 | 0 | |||
| Shares Outstanding | 1.48M | 44.10M | 34.60M | 33.90M | 24.50M | |||
| Tangible Book Value per Share | -9.77235 | 1.254 | 2.0925 | 2.8024 | 2.3061 | |||
| Total Shareholders' Equity | -14.46M | 55.30M | 72.40M | 95.00M | 56.50M | |||
| TOTAL LIABILITIES AND EQUITY | 38.83M | 120.10M | 126.40M | 143.60M | 105.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.72 | 0.33 | 0.33 | 0.54 | |||
| Current Ratio | 0.71 | 4.68 | 3.46 | 8.30 | 5.94 | |||
| Return On Assets (ROA) | -193.07% | -80.58% | -26.84% | -45.30% | -66.84% | |||
| Return On Equity (ROE) | N/A | -175.01% | -46.85% | -68.47% | -124.34% | |||
All data in USD , ROIC based on taxRate of 0.21